Aptevo Therapeutics Inc. (APVO) — 8-K Filings

8-K Filings (36)

• Aptevo Therapeutics Files 8-K on Financials — Mar 26, 2026 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on March 26, 2026, reporting on its results of operations and financial condition. The filing includes financial statement
• Aptevo Therapeutics Files 8-K — Dec 29, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on December 29, 2025, reporting amendments to its articles of incorporation or bylaws and filing financial statements and
• Aptevo Therapeutics Files 8-K — Dec 9, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on December 9, 2025, reporting financial statements and exhibits. The company, incorporated in Delaware with its principal
• Aptevo Therapeutics Files 8-K: Material Agreement & Exhibits — Oct 30, 2025 Risk: medium
  On October 30, 2025, Aptevo Therapeutics Inc. filed an 8-K report. The filing indicates a material definitive agreement was entered into, modifications to secur
• Aptevo Therapeutics Files 8-K — Sep 16, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on September 16, 2025, reporting on other events and financial statements. The filing provides updated company information
• Aptevo Therapeutics Files 8-K — Sep 4, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on September 4, 2025, to report other events and financial statements. The filing does not contain specific details about
• Aptevo Therapeutics Files 8-K on Security Holder Vote Matters — Jul 24, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on July 24, 2025, to report on the submission of matters to a vote of its security holders. The filing does not contain de
• Aptevo Therapeutics Files 8-K Report — Jul 1, 2025 Risk: low
  On July 1, 2025, Aptevo Therapeutics Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific details regard
• Aptevo Therapeutics Files 8-K — Jun 30, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on June 30, 2025, reporting other events. The filing does not contain specific details about the nature of these events, d
• Aptevo Therapeutics Changes Auditors — Jun 23, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on June 23, 2025, to report changes in its certifying accountant. The company has appointed BDO USA, P.A. as its new indep
• Aptevo Therapeutics Files 8-K: Material Agreement — Jun 20, 2025 Risk: medium
  On June 18, 2025, Aptevo Therapeutics Inc. entered into a material definitive agreement. The company also reported other events and filed financial statements a
• Aptevo Therapeutics Files 8-K on Agreements and Equity Sales — Jun 17, 2025 Risk: medium
  On June 16, 2025, Aptevo Therapeutics Inc. filed an 8-K report detailing an entry into a material definitive agreement and unregistered sales of equity securiti
• Aptevo Therapeutics Files 8-K for Bylaw Amendments — May 23, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on May 23, 2025, reporting amendments to its articles of incorporation or bylaws and financial statements. The company, in
• Aptevo Therapeutics Faces Delisting Notice — May 22, 2025 Risk: high
  Aptevo Therapeutics Inc. filed an 8-K on May 22, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing also includes
• Aptevo Therapeutics Files 8-K — Apr 29, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on April 29, 2025, reporting other events and financial statements. The filing does not contain specific details on new ev
• Aptevo Therapeutics Files 8-K with Key Updates — Apr 28, 2025 Risk: medium
  Aptevo Therapeutics Inc. filed an 8-K on April 28, 2025, reporting on several key events. These include entering into a material definitive agreement, updates o
• Aptevo Therapeutics Files 8-K for Material Agreement — Apr 22, 2025 Risk: medium
  Aptevo Therapeutics Inc. filed an 8-K on April 22, 2025, reporting an entry into a material definitive agreement and other events. The filing details their prin
• Aptevo Therapeutics Files 8-K: Material Agreement — Apr 4, 2025 Risk: medium
  On April 3, 2025, Aptevo Therapeutics Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial st
• 8-K Filing — Mar 20, 2025
• Aptevo Therapeutics Files 8-K — Feb 11, 2025 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on February 11, 2025, reporting its status as a publicly traded company. The filing confirms its principal executive offic
• Aptevo Therapeutics Files 8-K — Dec 12, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on December 12, 2024, to report other events and financial statements. The filing does not contain specific details about
• Aptevo Therapeutics Files 8-K — Dec 4, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on December 4, 2024, to report other events and financial statements. The filing does not contain specific details about n
• Aptevo Therapeutics Files 8-K with Corporate Updates — Dec 3, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on December 3, 2024, reporting amendments to its articles of incorporation or bylaws and financial statements. The company
• Aptevo Therapeutics Files 8-K — Nov 26, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on November 26, 2024, to report other events and financial statements. The filing does not contain specific details about
• Aptevo Therapeutics Files 8-K — Nov 22, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on November 22, 2024, reporting other events and financial statements. The filing does not contain specific details about
• Aptevo Therapeutics Files 8-K — Nov 20, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on November 20, 2024, to report other events and financial statements. The filing does not contain specific details about
• Aptevo Therapeutics Files 8-K: Material Agreement & Security Holder Changes — Nov 4, 2024 Risk: medium
  Aptevo Therapeutics Inc. announced on November 1, 2024, that it entered into a material definitive agreement. The company also reported modifications to the rig
• Aptevo Therapeutics Reports on Shareholder Votes — Oct 25, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on October 25, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specifi
• Aptevo Therapeutics Files 8-K for Material Agreement — Sep 18, 2024 Risk: medium
  Aptevo Therapeutics Inc. filed an 8-K on September 18, 2024, reporting a material definitive agreement entered into on September 16, 2024. The filing also inclu
• Aptevo Therapeutics Files 8-K — Sep 16, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on September 16, 2024, reporting on other events and financial statements. The filing does not contain specific details on
• Aptevo Therapeutics Files 8-K on Shareholder Vote Matters — Aug 7, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on August 7, 2024, reporting on matters submitted to a vote of its security holders on August 6, 2024. The filing details
• Aptevo Therapeutics Files 8-K for Material Agreement — Jul 1, 2024 Risk: medium
  Aptevo Therapeutics Inc. announced on June 28, 2024, that it entered into a material definitive agreement. The company also reported other events and filed fina
• Aptevo Therapeutics Files 8-K on Security Holder Vote — Jun 10, 2024 Risk: medium
  Aptevo Therapeutics Inc. filed an 8-K on June 10, 2024, reporting on a matter submitted to a vote of its security holders as of June 7, 2024. The filing details
• Aptevo Therapeutics Files 8-K: Material Agreement — Apr 15, 2024 Risk: medium
  On April 10, 2024, Aptevo Therapeutics Inc. entered into a material definitive agreement. The company also reported other events and filed financial statements
• Aptevo Therapeutics Files 8-K — Mar 7, 2024 Risk: low
  Aptevo Therapeutics Inc. filed an 8-K on March 7, 2024, to report other events and financial statements. The filing does not contain specific details about new
• APTEVO THERAPEUTICS FILES 8-K ON SHAREHOLDER VOTE MATTERS — Feb 6, 2024
  Aptevo Therapeutics Inc. filed an 8-K on February 5, 2024, to report the submission of matters to a vote of security holders. This filing indicates that the com

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX